News

The guitar store is bringing the highly sought-after Widow design – and a recently revived finish – to players for less than $1,000 ...
Johnson & Johnson has decided to halt the development of selective kappa opioid receptor (KOR) antagonist aticaprant as a treatment for major depressive disorder (MDD), blowing a hole in its late ...
Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.